OTsENKA VYRAZhENNOSTI AVTONOMNOY KARDIAL'NOY NEYROPATII PRI SAKhARNOM DIABETE 1-go TIPA METODOM RITMOKARDIOGRAFII
- Authors: Nuzhdina EV1
-
Affiliations:
- Челябинская государственная медицинская академия, Россия
- Issue: Vol 30, No 2 (2013)
- Pages: 67-74
- Section: Articles
- URL: https://journals.rcsi.science/PMJ/article/view/3287
- DOI: https://doi.org/10.17816/pmj30267-74
- ID: 3287
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
E V Nuzhdina
Челябинская государственная медицинская академия, Россия
Email: evgenikud12@hotmail.com
аспирант кафедры профессиональных болезней и клинической фармакологии
References
- Балаболкин М. И. Диабетология. М.: Медицина 2000; 672.
- Миронова Т. В., Миронов В. А. Клинический анализ волновой структуры синусового ритма сердца (Введение в ритмокардиографию и атлас ритмокардиограмм). Челябинск 1998; 162.
- Ewing D. J., Campbell I. W., Clarke B. F. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann. Intern. Med. 1980; 92: 308–311.
- Kennedy W. R., Navarro X., Sutherland D. E. Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology 1995; 45: 773–780.
- Maser R. E., Mitchell B. D., Vinik A. I., Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003; 26: 1895–1901.
- Review: Rodica Pop-Busui. Cardiac autonomic neuropathy in diabetes: A clinical perspective. Diabetes Care 2010; 33: 434–441.
- Spallone V., Ziegler D., Freeman R., Bernardi L., Frontoni S., Pop-Busui R., Stevens M., Kempler P., Hilsted J., Tesfaye S., Low P., Valensi P. On behalf of the Toronto consensus panel on diabetic neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes. Metab. Res. Rev. 2011; 27: 639–653.
- The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes COntrol and complications trial (DCCT). Diabetologia 1998; 41: 416–423.
- Vinik A. I., Erbas T., Tae S., Stansberry K., Scanelli J. A., Pittenger G. L. Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care 2001; 24: 1468–1475.
- Wu J. S., Yang Y. C., Lin T. S., Huang Y. H., Chen J. J., Lu F. H. et al. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J. Clin. Endocrinol. Metab. 2007; 92: 3885–3889.
- Ziegler D., Zentai C. P., Perz S., Rathmann W., Haastert B., Doring A. et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and non-diabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care. 2008; 31: 556–561.
Supplementary files
